Alcanza Clinical Research

As CEO, Carlos Orantes provides leadership and strategic direction for the site network. With over 32 years of experience within the life sciences industry, his career has included executive leadership, operational management, LEAN Six Sigma process improvement, as well as systems and technology deployment.

Most recently, Carlos served as Executive Director, Site Operations at Accelerated Enrollment Solutions, now Trial Med, a business of PPD later acquired by ThermoFisher Scientific. There, he led the site operations for the Americas site operations in support of the company’s vast global clinical trial network.

Prior to joining PPD, Carlos served as Chief Executive Officer of Amplify Clinical and Accel Research Sites, where he developed the business strategy to effectively compete in Phase II-III clinical research involving multi-therapeutic trials and specialty vaccines. He also led activities related to both companies’ asset purchase by private equity.

Earlier career positions included COO for Frontage Laboratories and close to 20 years of operational, quality assurance, process improvement, and laboratory management roles of increasing responsibility at organizations including Covance, later becoming part of LabCorp and now Fortrea.

Carlos earned a Master of Business Administration degree from Old Dominion University, and a Bachelor of Science degree in Biology from George Washington University. He is a certified Lean Six Sigma Black Belt from Six Sigma Academy.